Filter
1023
Text search:
hazard
approach
Featured
113
308
Language
Document type
528
173
136
91
46
27
11
7
2
2
Countries / Regions
42
41
39
29
24
22
21
19
15
15
14
12
12
12
11
11
10
9
8
8
8
7
7
7
7
7
7
7
6
6
6
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
293
101
73
57
24
20
14
8
1
Toolboxes
110
91
80
69
47
43
40
37
33
32
27
27
26
24
24
15
12
12
6
6
3
3
2
1
1
For practitioners in humanitarian and development contexts
Towards the Peoples Health Assembly Book -4
DHS Working Papers No. 69
This paper uses data from the three Indian National Family Health Surveys (1992-93, 1998-99, 2005-06) to examine how the relationship between household wealth and child mortality evolved during a time of significant economic change in India. The main predictor is a new ...
This paper uses data from the three Indian National Family Health Surveys (1992-93, 1998-99, 2005-06) to examine how the relationship between household wealth and child mortality evolved during a time of significant economic change in India. The main predictor is a new ...
The EHSP in Botswana seeks to attain universal coverage of high-quality package of essential health services. The EHSP is an integrated collection of cost-effective interventions, promotive, preventive, curative, and rehabilitative, that address the main diseases, injuries and risk factors that affe
...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog
...
Policy framework.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
